关注
Jeremy Davis
Jeremy Davis
UCB
在 ucb.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Modulators of 14-3-3 protein–protein interactions
LM Stevers, E Sijbesma, M Botta, C MacKintosh, T Obsil, I Landrieu, ...
Journal of medicinal chemistry 61 (9), 3755-3778, 2017
2552017
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
PD Davis, DFC Moffat, JM Davis, MC Hutchings
US Patent 5,958,935, 1999
2351999
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
PD Davis, DFC Moffat, JM Davis, MC Hutchings
US Patent 6,235,746, 2001
2062001
5-cyano-2-aminopyrimidine derivatives
MJ Batchelor, DFC Moffat, JM Davis, MC Hutchings
US Patent 6,579,983, 2003
1762003
Stabilization of protein-protein interactions in drug discovery
SA Andrei, E Sijbesma, M Hann, J Davis, G O’Mahony, MWD Perry, ...
Expert opinion on drug discovery 12 (9), 925-940, 2017
1562017
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
J Porter, A Payne, B de Candole, D Ford, B Hutchinson, G Trevitt, J Turner, ...
Bioorganic & Medicinal Chemistry Letters 19 (1), 230-233, 2009
1322009
Formation of zirconocene η2-imine complexes by rearrangement of cyclic iminoacyl complexes.
JM Davis, RJ Whitby, A Jaxa-Chamiec
Tetrahedron letters 33 (38), 5655-5658, 1992
831992
c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis
H Chaudhury, M Zakkar, J Boyle, S Cuhlmann, K Van Der Heiden, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (3), 546-553, 2010
822010
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation
TV Hughes, SL Emanuel, AK Beck, SK Wetter, PJ Connolly, P Karnachi, ...
Bioorganic & medicinal chemistry letters 17 (12), 3266-3270, 2007
582007
4, 5-disubstituted-2-aminopyrimidines
JM Davis, DFC Moffat
US Patent 6,600,037, 2003
462003
Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation
J Porter, A Payne, I Whitcombe, B de Candole, D Ford, R Garlish, A Hold, ...
Bioorganic & medicinal chemistry letters 19 (6), 1767-1772, 2009
452009
Fused polycyclic 2-aminopyrimidine derivatives
JM Davis, PD Davis, DFC Moffat, MJ Batchelor
US Patent 6,057,329, 2000
442000
Fused polycyclic 2-aminopyrimidine derivatives
JM Davis, PD Davis, DFC Moffat, MJ Batchelor
US Patent 6,599,908, 2003
402003
Synthesis of cyclopentylamines using zirconium chemistry
JM Davis, RJ Whitby, A Jaxa-Chamiec
Tetrahedron letters 35 (9), 1445-1448, 1994
401994
Pyridine and pyrimidine derivatives
JM Davis, BJ Langham, M Naik, DC Brookings, RJ Cubbon, RJ Franklin
US Patent 7,323,464, 2008
372008
5-aminopyrazoles useful as tyrosine kinase inhibitors
PD Davis, JM Davis, DFC Moffat
US Patent 5,922,741, 1999
361999
Novel nucleotide triphosphates as potent P2Y2 agonists
D Brookings, RJ Davenport, J Davis, FCA Galvin, S Lloyd, SR Mack, ...
Bioorganic & medicinal chemistry letters 17 (2), 562-565, 2007
262007
Bicyclic oxopyridine and oxopyrimidine derivatives
JM Davis, DC Brookings, BJ Langham
US Patent 7,176,215, 2007
232007
Scalable Synthesis of the VEGF-R2 Kinase Inhibitor JNJ-17029259 Using Ultrasound-Mediated Addition of MeLi−CeCl3 to a Nitrile
M Reuman, S Beish, J Davis, MJ Batchelor, MC Hutchings, DFC Moffat, ...
The Journal of Organic Chemistry 73 (3), 1121-1123, 2008
222008
1-Azadiene complexes of zirconocene.
J Davis, R Whitby, A Jaxa-Chamiec
Chemical Communications 24, 1743, 1991
221991
系统目前无法执行此操作,请稍后再试。
文章 1–20